Loading clinical trials...

Bupropion for Depression in ESRD Patients on Hemodialysis | Clinical Trials | Clareo Health

TERMINATEDPhase 4NCT02238977

Bupropion for Depression in ESRD Patients on Hemodialysis

The proposed study will evaluate the response and remission rates for major depressive disorder (MDD) in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis (HD) treated with b...

Lead sponsor: University of Arkansas•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 4

Establishing Mobile Transcranial Magnetic Stimulation

NCT06748209 · Treatment Resistant Major Depression

RECRUITINGNA

Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients

NCT07157397 · End Stage Renal Disease (ESRD), End Stage Kidney Disease (ESRD), and more

RECRUITINGNA

CAPABLE Transplant

NCT06326905 · Quality of Life, Depression, and more

RECRUITINGPhase 3

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

NCT07020832 · Delayed Graft Function, End Stage Renal Disease, and more

RECRUITING

University of Iowa Interventional Psychiatry Service Patient Registry

NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 17, 2018Terms

Trial snapshot

StatusTERMINATED

PhasePHASE4

Enrollment1

Start dateMar 2016

Last updatedJul 17, 2018

Condition

Major Depression End Stage Renal Disease

Locations shown

University of Arkansas for Medical Sciences

Little Rock, Arkansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions